Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service.

Dawoud DM, Wonderling D, Glen J, Lewis S, Griffin XL, Hunt BJ, Stansby G, Reed M, Rossiter N, Chahal JK, Sharpin C, Barry P.

Front Pharmacol. 2018 Nov 27;9:1370. doi: 10.3389/fphar.2018.01370. eCollection 2018.

2.

Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis.

Dawoud DM, Smyth M, Ashe J, Strong T, Wonderling D, Hill J, Varia M, Dyer P, Bion J.

Res Social Adm Pharm. 2018 Oct 19. pii: S1551-7411(18)30652-1. doi: 10.1016/j.sapharm.2018.10.006. [Epub ahead of print]

PMID:
30389320
3.

The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic outcomes in stroke.

Xu XM, Vestesson E, Paley L, Desikan A, Wonderling D, Hoffman A, Wolfe CD, Rudd AG, Bray BD.

Eur Stroke J. 2018 Mar;3(1):82-91. doi: 10.1177/2396987317746516. Epub 2017 Nov 30.

4.

Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis.

Dawoud D, O'Mahony R, Wonderling D, Cobb J, Higgins B, Amiel SA.

Value Health. 2018 Feb;21(2):176-184. doi: 10.1016/j.jval.2017.04.024. Epub 2017 Jun 20. Review.

PMID:
29477399
5.

Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis.

Dawoud D, Fenu E, Higgins B, Wonderling D, Amiel SA.

Value Health. 2017 Dec;20(10):1279-1287. doi: 10.1016/j.jval.2017.05.021. Epub 2017 Jul 8.

6.

Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure.

Griffin EA, Wonderling D, Ludman AJ, Al-Mohammad A, Cowie MR, Hardman SMC, McMurray JJV, Kendall J, Mitchell P, Shote A, Dworzynski K, Mant J.

Value Health. 2017 Sep;20(8):1025-1033. doi: 10.1016/j.jval.2017.05.007. Epub 2017 Jul 11.

7.

Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale.

Ratcliffe LE, Thomas W, Glen J, Padhi S, Pordes BA, Wonderling D, Connell R, Stephens S, Mikhail AI, Fogarty DG, Cooper JK, Dring B, Devonald MA, Brown C, Thomas ME.

Am J Kidney Dis. 2016 Apr;67(4):548-58. doi: 10.1053/j.ajkd.2015.11.012. Epub 2016 Jan 4.

PMID:
26763385
8.

Basal Insulin Regimens: Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults.

Dawoud D, Fenu E, Wonderling D, O'Mahony R, Pursey N, Cobb J, Amiel SA, Higgins B.

Value Health. 2015 Nov;18(7):A339. doi: 10.1016/j.jval.2015.09.136. Epub 2015 Oct 20. No abstract available.

9.

A Cost-effectiveness Analysis of Surgery, Endothermal Ablation, Ultrasound-guided Foam Sclerotherapy and Compression Stockings for Symptomatic Varicose Veins.

Marsden G, Perry M, Bradbury A, Hickey N, Kelley K, Trender H, Wonderling D, Davies AH.

Eur J Vasc Endovasc Surg. 2015 Dec;50(6):794-801. doi: 10.1016/j.ejvs.2015.07.034. Epub 2015 Oct 2. Review.

10.

Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.

Sawyer LM, Wonderling D, Jackson K, Murphy R, Samarasekera EJ, Smith CH.

Pharmacoeconomics. 2015 Feb;33(2):163-77. doi: 10.1007/s40273-014-0226-y.

PMID:
25526841
11.

A Cost-Effectiveness Analysis Of Interventions For Symptomatic Varicose Veins.

Marsden G, Perry M, Bradbury A, Hickey N, Kelley K, Trender H, Wonderling D, Davies AH.

Value Health. 2014 Nov;17(7):A488-9. doi: 10.1016/j.jval.2014.08.1438. Epub 2014 Oct 26. No abstract available.

12.

Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance.

Carville S, Wonderling D, Stevens P; Guideline Development Group.

BMJ. 2014 Jul 24;349:g4507. doi: 10.1136/bmj.g4507. No abstract available.

PMID:
25059691
13.

Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.

Lord J, Willis S, Eatock J, Tappenden P, Trapero-Bertran M, Miners A, Crossan C, Westby M, Anagnostou A, Taylor S, Mavranezouli I, Wonderling D, Alderson P, Ruiz F.

Health Technol Assess. 2013 Dec;17(58):v-vi, 1-192. doi: 10.3310/hta17580.

14.

Trial-based cost-effectiveness analysis comparing surgical and endoscopic drainage in patients with obstructive chronic pancreatitis.

Laramée P, Wonderling D, Cahen DL, Dijkgraaf MG, Gouma DJ, Bruno MJ, Pereira SP.

BMJ Open. 2013 Sep 23;3(9):e003676. doi: 10.1136/bmjopen-2013-003676.

15.

Nutritional screening for improving professional practice for patient outcomes in hospital and primary care settings.

Omidvari AH, Vali Y, Murray SM, Wonderling D, Rashidian A.

Cochrane Database Syst Rev. 2013 Jun 6;(6):CD005539. doi: 10.1002/14651858.CD005539.pub2. Review.

PMID:
23744516
16.

Cost-effectiveness analysis: role and implications.

Marsden G, Wonderling D.

Phlebology. 2013 Mar;28 Suppl 1:135-40. doi: 10.1177/0268355512475119. Review. Erratum in: Phlebology. 2013 Apr;28(3):173.

PMID:
23482549
17.

Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses.

Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH.

Br J Dermatol. 2013 May;168(5):954-67. doi: 10.1111/bjd.12276. Review.

18.

Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.

Sawyer L, Samarasekera EJ, Wonderling D, Smith CH.

Br J Dermatol. 2013 May;168(5):1095-105. doi: 10.1111/bjd.12261.

19.

Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials.

Bodalia PN, Grosso AM, Sofat R, Macallister RJ, Smeeth L, Dhillon S, Casas JP, Wonderling D, Hingorani AD.

Br J Clin Pharmacol. 2013 Nov;76(5):649-67. doi: 10.1111/bcp.12083. Review.

20.

Cost-effectiveness analysis of serial measurement of circulating natriuretic peptide concentration in chronic heart failure.

Laramée P, Wonderling D, Swain S, Al-Mohammad A, Mant J.

Heart. 2013 Feb;99(4):267-71. doi: 10.1136/heartjnl-2012-302692. Epub 2012 Dec 12.

PMID:
23236028

Supplemental Content

Loading ...
Support Center